Cefepime vs carbapenems for treating third-generation cephalosporin-resistant AmpC β-lactamase-hyperproducing Enterobacterales bloodstream infections: a multicenter retrospective studyBaptiste Hoellinger, Axel Ursenbach, François Séverac et al.|International Journal of Infectious Diseases|2023Cited by 17
Incidence and Time-to-Onset of Carbapenemase-Producing Enterobacterales (CPE) Infections in CPE Carriers: a Retrospective Cohort StudyBaptiste Hoellinger, Y. Hansmann, Stéphanie Deboscker et al.|Microbiology Spectrum|2022Cited by 16
Factors associated with treatment failure after advice from infectious disease specialistsAurélie Martin, Nicolas Lefèbvre, Y. Hansmann et al.|Médecine et Maladies Infectieuses|2019Cited by 1